Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1

被引：0
|
作者：
Tomoo Miyauchi
Tatsuo Kanda
Fumio Imazeki
Rintaro Mikata
Akinobu Tawada
Makoto Arai
Keiichi Fujiwara
Shingo Nakamoto
Shuang Wu
Takeshi Tanaka
Tatsuo Miyamura
Michio Kimura
Yasuo Hirai
Motohide Takashi
Shigeru Mikami
Nobuyuki Sugiura
Yutaka Natsuki
Ryosaku Azemoto
Noriaki Suzuki
Osamu Yokosuka
机构：
[1] Chiba University,Department of Medicine and Clinical Oncology, Graduate School of Medicine
[2] Social Insurance Funabashi Chuo Hospital,undefined
[3] Matsudo City Hospital,undefined
[4] Saiseikai Narashino Hospital,undefined
[5] Kikkoman Hospital,undefined
[6] National Hospital Organization Chiba Medical Center,undefined
[7] Sannou Hospital Medical Center,undefined
[8] Kimitsu Chuo Hospital,undefined
来源：
Hepatology International | 2013年 / 7卷
关键词：
Age; Gender; Genotype 1; HCV; Ribavirin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：144 / 152
页数：8
相关论文
共 50 条
  • [31] Response-guided peginterferon-alpha-2b plus ribavirin therapy for chronic hepatitis C patients with genotype 2 and high viral loads
    Sato, Ken
    Hashizume, Hiroaki
    Yamazaki, Yuichi
    Horiguchi, Norio
    Kakizaki, Satoru
    Takagi, Hitoshi
    Mori, Masatomo
    HEPATOLOGY RESEARCH, 2012, 42 (09) : 854 - 863
  • [32] Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin
    Harrison, Stephen A.
    Hamzeh, Fayez M.
    Han, Jian
    Pandya, Prashant K.
    Sheikh, Muhammed Y.
    Vierling, John M.
    HEPATOLOGY, 2012, 56 (02) : 464 - 473
  • [33] PREDICTION OF RESPONSE TO PEGINTERFERON-ALFA-2B PLUS RIBAVIRIN THERAPY IN JAPANESE PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 1B
    Hashimoto, Yoshimasa
    Ochi, Hidenori
    Maekawa, Toshiro
    Abe, Hiromi
    Tsuge, Masataka
    Mitsui, Fukiko
    Hiraga, Nobuhiko
    Imamura, Michio
    Takahashi, Shoichi
    Hayes, C. Nelson
    Ohishi, Waka
    Chayama, Kazuaki
    HEPATOLOGY, 2010, 52 (04) : 1210A - 1210A
  • [34] Impact of reducing peginterferon alfa-2b and ribavirin on early viral response in genotype 1 infected patients with chronic hepatitis C
    Oze, Tsugiko
    Hiramatsu, Naoki
    Inoue, Yuko
    Kurashige, Nao
    Kurokava, Mika
    Yakushijin, Takayuki
    Igura, Takumi
    Imanaka, Kazuhiro
    Yoshihara, Harumosa
    Inoue, Atsuo
    Imai, Yasuharu
    Hayashi, Eijirou
    Kato, Michio
    Nishikawa, Masahiro
    Minami, Yuzo
    Tatsumi, Tomohide
    Kanto, Tatsuya
    Takehara, Tetsuo
    Kasahara, Akinori
    Tamura, Shinji
    Hayashi, Norio
    HEPATOLOGY, 2007, 46 (04) : 377A - 377A
  • [35] Prediction of Response to Peginterferon-Alfa-2b Plus Ribavirin Therapy in Japanese Patients Infected With Hepatitis C Virus Genotype 1b
    Hashimoto, Yoshimasa
    Ochi, Hidenori
    Abe, Hiromi
    Hayashida, Yasufumi
    Tsuge, Masataka
    Mitsui, Fukiko
    Hiraga, Nobuhiko
    Imamura, Michio
    Takahashi, Shoichi
    Hayes, C. Nelson
    Ohishi, Waka
    Kubo, Michaki
    Tsunoda, Tatsuhiko
    Kamatani, Naoyuki
    Nakamura, Yusuke
    Chayama, Kazuaki
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (06) : 981 - 988
  • [36] VIRAL DYNAMICS AND EARLY VIRAL RESPONSE AT WEEK 4 IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON α2B AND RIBAVIRIN
    Loaeza del Castillo, Aurora
    Sixtos-Alonso, S.
    Sanchez-Avila, F.
    Uribe, M.
    HEPATOLOGY, 2009, 50 (04) : 965A - 965A
  • [37] Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting
    Giordanino, Chiara
    Sacco, Marco
    Ceretto, Simone
    Smedile, Antonina
    Ciancio, Alessia
    Cariti, Giuseppe
    De Blasi, Tiziano
    Picciotto, Antonio
    Marenco, Simona
    Grasso, Alessandro
    Pirisi, Mario
    Smirne, Carlo
    Colletta, Cosimo
    Traverso, Antonio
    Mazzucco, Dario
    Ciccone, Giovannino
    Simondi, Daniele
    Rizzetto, Mario
    Saracco, Giorgio
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (01) : 52 - 58
  • [38] Cost Effectiveness of Peginterferon α-2a and Peginterferon α-2b Combination Regimens in Genotype-1 Naive Patients with Chronic Hepatitis C
    Gheorghe, Liana
    Baculea, Simona
    HEPATO-GASTROENTEROLOGY, 2010, 57 (101) : 939 - 944
  • [39] Peginterferon α-2b and ribavirin therapy in chronic hepatitis C genotype 4:: impact of treatment duration and viral kinetics on sustained virological response
    Kamal, SM
    El Tawil, AA
    Nakano, T
    He, Q
    Rasenack, J
    Hakam, SA
    Saleh, WA
    Ismail, A
    Aziz, AA
    Madwar, MA
    GUT, 2005, 54 (06) : 858 - 866
  • [40] Peginterferon alfa-2b and ribavirin treatment response among Hispanic veterans with chronic hepatitis C genotype 1
    Toro, D
    De Jesus, JJ
    Rodriguez-Perez, F
    Gonzalez, D
    Rivera, I
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S122 - S123
12345